Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

2(66.7%)

Phase 1

1(33.3%)

3Total

N/A(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05727020Recruiting

Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma

Role: collaborator

NCT07243262Recruiting

Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)

Role: collaborator

NCT03983707Completed

A Evaluation of the Utilisation, Effectiveness and Safety of Purastat® in the Management of Gastrointestinal Bleeding

Role: collaborator

NCT05774587Not ApplicableCompleted

Mobile Health for Cardiac Rehabilitation (Motivate-CR+)

Role: collaborator

NCT04202991Completed

The Relationship Between Pain, Balance and Gait in People With Chronic Obstructive Pulmonary Disease

Role: collaborator

NCT05068154Unknown

Myovista vs NT Pro-BNP Heart Failure Referral Tool

Role: collaborator

NCT03663062Completed

ObeSity Related Colorectal Adenoma Risk

Role: collaborator

NCT01626963Phase 1Unknown

Single-port Versus Conventional Laparoscopic Colorectal Surgery

Role: lead

NCT02668263Not ApplicableUnknown

Investigating the Use of Drains and (Internal) Quilting Sutures on Seroma Formation Following Mastectomy

Role: lead

All 9 trials loaded